temozolomide
An oral chemotherapy drug (TMZ) standard for glioblastoma alongside radiation
As defined in Novocure: Using Physics to Fight Cancer
Where it comes up · 1
Most important claims · 3 of 3Search all claims for “temozolomide” →
- In the pivotal glioblastoma trial, the control group receiving radiation plus temozolomide had about 5 percent five-year survival, while adding Tumor Treating Fields raised five-year survival to about 13 percent, with survival curves separating at every point.Novocure: Using Physics to Fight Cancer
- In the control arm, glioblastoma patients receiving maximal debulking surgery, radiation, and temozolomide had a five-year survival of about 5 percent, which Bill called essentially no chance of five-year survival.Novocure: Using Physics to Fight Cancer
- Standard GBM care is maximum debulking surgery followed by as much radiation as tolerated, then temozolomide, a long-used chemotherapy that only modestly extends life expectancy, and radiation dose is capped by neurocognitive toxicity.Novocure: Using Physics to Fight Cancer